JNJ strikes huge vax deal with White House
COVID deaths top 700k
US to send DHHS Secretary Alex Azar on historic visit to Taiwan
Czech Republic reports biggest jump in new cases since June
Poland suffers record deaths
WHO sends team of 43 to South Africa
Uganda is Africa's standout COVID success story
WHO says first "confirmed" North Korea COVID cases "inconclusive"
Queensland, Australia bars travelers from all Eastern states
* * *
Update (0910ET): JNJ shares are soaring in premarket trading after the company announced that it had struck a deal for 100 million doses of its COVID-19 vaccine candidate, the latest in a string of blockbuster deals for vaccine candidates as governments, including the US, UK, EU and Japan, scramble to stockpile vaccine doses before they're even approved.
BARDA, the US agency in charge of these deals, is pledging $1 billion+ for this deal, at roughyl $10/dose, making JNJ's one of the cheaper vaccine candidates.
And with J&J-US govt supply agreement just now, here's where pricing lining up for first contracts for #COVID19 vaccines in US:— Meg Tirrell (@megtirrell) August 5, 2020
Moderna: guiding toward $32-$37/dose depending on size of contract
(AZ lowest but grant also supports dev) https://t.co/ZPsUpRWPA9